Aerosol Delivery of Functionalized Gold Nanoparticles Target and Activate Dendritic Cells in a 3D Lung Cellular Model.

Nanocarrier design combined with pulmonary drug delivery holds great promise for the treatment of respiratory tract disorders. In particular, targeting of dendritic cells that are key immune cells to enhance or suppress an immune response in the lung is a promising approach for the treatment of allergic diseases. Fluorescently encoded poly(vinyl alcohol) (PVA)-coated gold nanoparticles, functionalized with either negative (-COO-) or positive (-NH3+) surface charges, were functionalized with a DC-SIGN antibody on the particle surface, enabling binding to a dendritic cell surface receptor. A 3D coculture model consisting of epithelial and immune cells (macrophages and dendritic cells) mimicking the human lung epithelial tissue barrier was employed to assess the effects of aerosolized AuNPs. PVA-NH2 AuNPs showed higher uptake compared to that of their -COOH counterparts, with the highest uptake recorded in macrophages, as shown by flow cytometry. None of the AuNPs induced cytotoxicity or necrosis or increased cytokine secretion, whereas only PVA-NH2 AuNPs induced higher apoptosis levels. DC-SIGN AuNPs showed significantly increased uptake by monocyte-derived dendritic cells (MDDCs) with subsequent activation compared to non-antibody-conjugated control AuNPs, independent of surface charge. Our results show that DC-SIGN conjugation to the AuNPs enhanced MDDC targeting and activation in a complex 3D lung cell model. These findings highlight the potential of immunoengineering approaches to the targeting and activation of immune cells in the lung by nanocarriers.

[1]  Pedro V. Baptista,et al.  Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine , 2014, Front. Chem..

[2]  I. Mellman,et al.  Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination , 2006, Nature.

[3]  J. Patton,et al.  The lungs as a portal of entry for systemic drug delivery. , 2004, Proceedings of the American Thoracic Society.

[4]  J. Turkevich,et al.  Coagulation of Colloidal Gold , 2002 .

[5]  F. Toldrá,et al.  Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Foodon a request from the Commission related to an applicationon the use of cassia gum as a food additive , 2006 .

[6]  Peter R. Byron,et al.  Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.

[7]  C. Kurts,et al.  Dendritic cell-targeted vaccines — hope or hype? , 2014, Nature Reviews Immunology.

[8]  Peter Wick,et al.  Repeated exposure to carbon nanotube-based aerosols does not affect the functional properties of a 3D human epithelial airway model , 2015, Nanotoxicology.

[9]  O. Schmid,et al.  Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. , 2010, Toxicology and applied pharmacology.

[10]  W. Stoorvogel,et al.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting. , 2013, Cold Spring Harbor perspectives in biology.

[11]  Alke Petri-Fink,et al.  Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells , 2011, Nanotoxicology.

[12]  A. Ram,et al.  Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN. , 2014, ACS chemical biology.

[13]  J. Villadangos,et al.  MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. , 2001, Immunity.

[14]  Douglas M. Smith,et al.  Applications of nanotechnology for immunology , 2013, Nature Reviews Immunology.

[15]  E R Weibel,et al.  The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. , 1978, Respiration physiology.

[16]  Valeria Grazú,et al.  Designing novel nano-immunoassays: antibody orientation versus sensitivity , 2010 .

[17]  B. Rothen‐Rutishauser,et al.  An optimized in vitro model of the respiratory tract wall to study particle cell interactions. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[18]  Barbara Rothen-Rutishauser,et al.  A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles , 2009, Particle and Fibre Toxicology.

[19]  C. von Garnier,et al.  Immunology taught by lung dendritic cells. , 2009, Swiss medical weekly.

[20]  M. Moniatte,et al.  Surface charge of polymer coated SPIONs influences the serum protein adsorption, colloidal stability and subsequent cell interaction in vitro. , 2013, Nanoscale.

[21]  B. Rothen‐Rutishauser,et al.  Pulmonary delivery of cationic gold nanoparticles boost antigen-specific CD4+ T Cell Proliferation. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[22]  N. Peppas,et al.  Swelling/deswelling of anionic copolymer gels. , 1995, Biomaterials.

[23]  J. Falcón-Pérez,et al.  Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. , 2012, Bioconjugate chemistry.

[24]  B. Rothen‐Rutishauser,et al.  Fluorescence-encoded gold nanoparticles: library design and modulation of cellular uptake into dendritic cells. , 2014, Small.

[25]  J. Munch,et al.  Swelling and Elastic Properties of Polyelectrolyte Gels , 1995 .

[26]  Wolfgang G Kreyling,et al.  The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. , 2013, Biomaterials.

[27]  P. Wick,et al.  Inhalation Pathway as a Promising Portal of Entry: What Has to Be Considered in Designing New Nanomaterials for Biomedical Application? , 2014 .

[28]  Katrin Schwarz,et al.  Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.

[29]  J. Heyder,et al.  Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .

[30]  B. Narasimhan,et al.  Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells. , 2011, Molecular pharmaceutics.

[31]  M. Marelli,et al.  Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles. , 2014, Bioconjugate chemistry.

[32]  Jeremy D. Driskell,et al.  Rapid screening of antibody–antigen binding using dynamic light scattering (DLS) and gold nanoparticles , 2015 .

[33]  J. Villadangos,et al.  Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces , 2005, Immunological reviews.

[34]  Dimitri Vanhecke,et al.  Quantification of nanoparticles at the single-cell level: an overview about state-of-the-art techniques and their limitations. , 2014, Nanomedicine.

[35]  Natalie von Goetz,et al.  Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments , 2015, Particle and Fibre Toxicology.

[36]  A. Baas,et al.  FDA-approved poly(ethylene glycol)–protein conjugate drugs , 2011 .

[37]  F. Ginhoux,et al.  Human dendritic cells. , 2019, Seminars in cell & developmental biology.

[38]  Dimitri Vanhecke,et al.  A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry , 2017, Scientific Reports.

[39]  P. Holt,et al.  Characterization of dendritic cell populations in the respiratory tract. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[40]  Chih-Hung Hsu,et al.  Induction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cells. , 2013, Auris, nasus, larynx.

[41]  M. Vélez,et al.  Useful oriented immobilization of antibodies on chimeric magnetic particles: direct correlation of biomacromolecule orientation with biological activity by AFM studies. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[42]  Christian Mühlfeld,et al.  Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. , 2010, Small.

[43]  M. Dhodapkar,et al.  Crosstalk Dependent DC − Activation via IL-15 ( DC ) Subsets Leads to Enhanced T Cell Targeting of Multiple Human Dendritic Cell Nanoparticle-Mediated Combinatorial , 2014 .

[44]  A. Hendi,et al.  Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[45]  C. vonGarnier,et al.  Immunology taught by lung dendritic cells. , 2009 .

[46]  C. Figdor,et al.  Targeting dendritic cells--why bother? , 2013, Blood.

[47]  M. Dhodapkar,et al.  Nanoparticle-Mediated Combinatorial Targeting of Multiple Human Dendritic Cell (DC) Subsets Leads to Enhanced T Cell Activation via IL-15–Dependent DC Crosstalk , 2014, The Journal of Immunology.

[48]  Dimitri Vanhecke,et al.  Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[49]  Peter Gehr,et al.  A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. , 2005, American journal of respiratory cell and molecular biology.

[50]  Claudio Parolo,et al.  Design, preparation, and evaluation of a fixed-orientation antibody/gold-nanoparticle conjugate as an immunosensing label. , 2013, ACS applied materials & interfaces.

[51]  Fernando Albericio,et al.  Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. , 2010, Journal of controlled release : official journal of the Controlled Release Society.